Efficacy of Flunarizine Vs Amitriptyline in Prophylaxis of Migraine Prophylaxis
NCT06162819 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84
Last updated 2023-12-29
Summary
To compare the frequency of acute attack and mean pain score ( assessed by visual analog scale) among subjects using either flunarizine or amitriptyline among patients with migraine coming to tertiary care Hospital in Lahore, Pakistan.
In this study 84 patients with migraine Age ranged between 18- 60 years, Both genders having 3 or more migraine attacks per month, normal systemic and neurological examination and not having taken any prophylactic medication for the last 4 months will randomly divided into two equal group of 42 subjects each.
Conditions
- Migraine
- Prophylaxis
Interventions
- DRUG
-
Amitriptyline
Amitriptyline will be used for prophylaxis of migraine, also used as antidepressant
- DRUG
-
Flunarizine 5mg
Flunarizine will be used for prophylaxis of migraine,
Sponsors & Collaborators
-
Shalamar Institute of Health Sciences
lead OTHER
Principal Investigators
-
Mujeeb-ur-Rehman Abid Butt, FCPS · Shalamar Institute of Health Sciences
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-01
- Primary Completion
- 2024-06-30
- Completion
- 2024-09-30
Countries
- Pakistan
Study Locations
More Related Trials
-
Efficacy and Safety of Oral Sumatriptan Plus Oral Promethazine in Migraine Treatment
NCT01814189 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine
NCT01390324 ·Status: WITHDRAWN ·Phase: PHASE3
-
Topiramate, Amitriptyline Monotherapy and Combination Therapy in Migraine Prophylaxis
NCT05759845 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine
NCT02828020 ·Status: COMPLETED ·Phase: PHASE3
-
Comparing the Safety and Effectiveness of Topiramate With the Safety and Effectiveness of Amitriptyline in Preventing Migraine Headaches
NCT00210821 ·Status: COMPLETED ·Phase: PHASE3
-
Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of Migraine Aura
NCT04063540 ·Status: RECRUITING ·Phase: PHASE2
-
Low-Dose Naltrexone and Acetaminophen Combination and Its Components in the Acute Treatment of Migraine
NCT03061734 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain
NCT03877718 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study to Assess Change in Disease Activity When Ubrogepant Tablets Are Combined With Atogepant Tablets to Treat Migraine in Adult Participants
NCT05653986 ·Status: COMPLETED
-
Low-Dose Naltrexone and Acetaminophen Combination and Sumatriptan in the Acute Treatment of Migraine With Nausea
NCT03185143 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Lacosamide Versus Propranolol in Migraine
NCT05851781 ·Status: COMPLETED ·Phase: PHASE3
-
Fremanezumab for the Prevention of Menstrually-related Migraine Attacks
NCT06659120 ·Status: RECRUITING
-
A Randomized,Double Blind, Placebo Controlled Study to Assess Efficacy,Safety and Tolerability of BGG492 in Migraine Prevention
NCT01617941 ·Status: WITHDRAWN ·Phase: PHASE2
-
An Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine Attack
NCT00330850 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Effectiveness of First-line Preventive Treatment of Migraine in Primary Care
NCT06499116 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
A Randomized Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine
NCT03836664 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months
NCT00792103 ·Status: COMPLETED ·Phase: PHASE3
-
Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period
NCT00723983 ·Status: COMPLETED ·Phase: PHASE1
-
Amitriptyline vs GON and SON Blocks in Migraine
NCT04750967 ·Status: COMPLETED ·Phase: NA
-
Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic Migraine
NCT03828539 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine
NCT03855137 ·Status: COMPLETED ·Phase: PHASE3
-
Zonisamide Versus Propranolol in Migraine
NCT06361446 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications
NCT05518123 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Learn About Zavegepant as a Treatment for Multiple Migraine Attacks in Adult Participants
NCT06103734 ·Status: WITHDRAWN ·Phase: PHASE3
-
Study to Evaluate the PK of BMS-927711 in Patient With Migraine During Acute Migraine and Non-migraine Condition
NCT01445067 ·Status: COMPLETED ·Phase: PHASE1